THIS PAGE HAS BEEN ARCHIVED AND IS NO LONGER UPDATED.
We apologize for the inconvenience.
To find similar material or the current version of the page, please visit one the following resources:
Health Topics || Country Sites || News Releases || Our New Homepage


ESTA PÁGINA HA SIDO ARCHIVADA Y YA NO ES ACTUALIZADA.
Pedimos disculpas por la molestia.
Para encontrar material similar o una versión actualizada de la página, visite uno de los siguientes recursos:
Temas de salud || Sitios de países || Comunicados de prensa || Nuestra nueva página de inicio


Carpeta Publications: Essential Medicines and Biologicals

Documentos

pdf Economic evaluation of oxytocin in Uniject™ injection system versus standard use of oxytocin for the prevention of postpartum hemorrhage in the active management of the third stage of labor in Latin America and the Caribbean  Publicado Popular

4809 descargas

Technical Report N° 12 ISSN 1668-2769 Economic evaluation of oxytocin in Uniject™ injection system versus standard use of oxytocin for the prevention of postpartum hemorrhage in the active management of the third stage of labor in Latin America and the Caribbean. Technical report IECS N° 12. Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina. December 2013.

pdf Access to High Cost Medicines in the Americas  Publicado Popular

3763 descargas

Access to High Cost Medicines in the Americas

pdf Boas práticas da OMS para laboratórios de microbiología farmacêutica. Washington, DC: OPS, 2012. (Rede PARF Documento Técnico Nº 11).  Publicado Popular

4607 descargas

Boas práticas da OMS para laboratórios de microbiología farmacêutica. Washington, DC: OPS, 2012.

(Rede PARF Documento Técnico Nº 11).

 

pdf Buenas prácticas de la OMS para laboratorios d e microbiología farmacéutica. Washington, DC: OPS, 2012. (Red PARF Documento Técnico Nº 11).  Publicado Popular

16554 descargas

Organización Mundial de la Salud

Buenas prácticas de la OMS para laboratorios d e microbiología farmacéutica. Washington, DC: OPS, 2012. (Red PARF Documento Técnico Nº 11).

 

pdf PANDRH Technical Document n.10. Requirements for Medicines Registration in the Americas. [2013]  Publicado Popular

2490 descargas

Requirements for Medicines Registration in the Americas. Washington, DC : PAHO, 2013.

(Pan American Network on Drug Regulatory Harmonization - PANDRH, Technical Document n.10).

1. Pharmaceutical Services - legislation & jurisprudence.  2. Pharmacy Administration.
3. Legislation, Pharmacy. 4. Research Report.  5. Americas. I. Title.

ISBN 978-92-75-11757-6                                                                              

pdf Pharmaceutical Situation in Jamaica. WHO Assessment of Level II - Health Facilities and Household Survey [2012]  Publicado Popular

5140 descargas

PAHO HQ Library Cataloguing-in-Publication Data
Pan American Health Organization, Ministry of Health of Jamaica.
Pharmaceutical Situation in Jamaica. WHO Assessment of Level II - Health Facilities and Household Survey. Washington, D.C.: PAHO, 2012.

(Technical Series: Essential Medicines, Pharmaceutical Policies, Nº 5)
ISBN 978-92-75-11697-5
I. Title. II. Series
1. Pharmaceutical services
2. Pharmacy administration
3. Health facilities
4. Data collection
5. Americas
(NLM Classification: WA730 DJ2)

pdf Pharmaceutical Situation in Saint Lucia. WHO Assessment of Level II. [2012].  Publicado Popular

2942 descargas

Pan American Health Organization, Ministry of Health of Saint Lucia.

Pharmaceutical Situation in Saint Lucia. WHO Assessment of Level II - Health Facilities Survey. Washington, D.C.: PAHO, 2012.
ISBN 978-92-75-11696-8
I. Title.
1. Pharmaceutical services
2. Pharmacy administration
3. Health facilities
4. Data collection
5. Americas
(NLM Classification: WA730 DS12)

pdf  Pharmaceutical Situation in Saint Lucia. WHO Assessment of Level II. [2012]. (1.01 MB)

pdf The Pharmaceutical situation in the Caribbean: Monitoring indicators 2010-2012  Publicado Popular

2170 descargas

The data presented are related to the pharmaceutical situation of 11 Caribbean countries and two United Kingdom Overseas Territories (UKOTs)- Antigua and Barbuda, Barbados, Dominica, Grenada, Guyana, Jamaica, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, British Virgin Islands and Turks and Caicos Islands- using information collected from 2010 to 2012 within the framework of the Pharmaceutical Sector Country Profiles project. The percentages in the report have been calculated in relation to the total number of respondents for each question. The Caribbean data are compared with that for the Americas region (with a total of 28 participating countries/UKOTs), where possible. Only the information provided by the countries along with an official signed endorsement were included in the individual pharmaceutical country profile and in this publication.